Activation of NOD2-mediated intestinal pathway in a pediatric population with Crohn's disease.
about
Control of NOD2 and Rip2-dependent innate immune activation by GEF-H1RIP2 activity in inflammatory disease and implications for novel therapeuticsThe role of innate immunity receptors in the pathogenesis of inflammatory bowel diseaseResearch Advance in Intestinal Mucosal Barrier and Pathogenesis of Crohn's DiseaseGenetic deletion of the bacterial sensor NOD2 improves murine Crohn's disease-like ileitis independent of functional dysbiosis.Inhibition of RIP2's tyrosine kinase activity limits NOD2-driven cytokine responses.Effect of bifidobacterium on defensin-5 expression in intestinal injury of preweaning rats.Enteric alpha defensins in norm and pathology.Inflammatory Signaling by NOD-RIPK2 Is Inhibited by Clinically Relevant Type II Kinase Inhibitors.Ubiquitination and phosphorylation in the regulation of NOD2 signaling and NOD2-mediated diseaseThe deubiquitinase A20 in immunopathology of autoimmune diseases.The dual role of nod-like receptors in mucosal innate immunity and chronic intestinal inflammation.Nucleotide-binding oligomerization domain (NOD) signaling defects and cell death susceptibility cannot be uncoupled in X-linked inhibitor of apoptosis (XIAP)-driven inflammatory disease.NOD2 Is Regulated By Mir-320 in Physiological Conditions but this Control Is Altered in Inflamed Tissues of Patients with Inflammatory Bowel Disease.In vivo inhibition of RIPK2 kinase alleviates inflammatory disease.Functional defects in NOD2 signaling in experimental and human Crohn disease.Association of RIP2 gene polymorphisms and systemic lupus erythematosus in a Chinese population.
P2860
Q24337154-BE2550EE-1D53-41C9-A2CC-5F484C1EF9E0Q27025050-BA72F1BC-027C-49CC-9C5B-FA8EEED78D15Q27027809-A3588D79-ABD9-405F-84C4-4B3FE79B1197Q28066444-4B4D4ABA-BBED-48BA-B47A-C9C741525A5AQ33694206-265D05B6-002D-479D-BEF9-E1474A7540A7Q34362422-E669A2BF-3BEB-4C40-8E22-DEA64A03B6D6Q35152314-D899F4D6-B450-457C-805C-19DA3C8160FBQ35712324-C46A9932-A0CD-47AC-A6B3-37C10D1F67B2Q36084130-EF602525-B6A9-4AB4-BEE5-D0624E2E603DQ38004338-5D495015-38FE-4B79-886C-53DC34DC3EE7Q38199722-4AB2EC75-059F-4154-8F04-43BD4C447F7FQ38234947-86B64111-44D5-4C7A-A0F3-F6EB195548B0Q38707914-07D08909-7889-4AB6-9431-109A069A39AEQ38804870-D553495E-84B1-4D60-91C6-E0A3F77B3A23Q41742020-033E9FC5-2D65-4738-981C-C6391E9C3C61Q42018048-C7E091E8-BCFD-429F-8D9D-E75A746B88ADQ54550680-9DBEC654-1ED8-484F-B21D-3AFBC6087002
P2860
Activation of NOD2-mediated intestinal pathway in a pediatric population with Crohn's disease.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Activation of NOD2-mediated in ...... pulation with Crohn's disease.
@en
Activation of NOD2-mediated in ...... pulation with Crohn's disease.
@nl
type
label
Activation of NOD2-mediated in ...... pulation with Crohn's disease.
@en
Activation of NOD2-mediated in ...... pulation with Crohn's disease.
@nl
prefLabel
Activation of NOD2-mediated in ...... pulation with Crohn's disease.
@en
Activation of NOD2-mediated in ...... pulation with Crohn's disease.
@nl
P2093
P2860
P50
P356
P1476
Activation of NOD2-mediated in ...... pulation with Crohn's disease.
@en
P2093
Anna Negroni
Donatella Tirindelli
Giulia Maiella
Maria Pierdomenico
Valentina Mancini
P2860
P304
P356
10.1002/IBD.20907
P577
2009-08-01T00:00:00Z